Literature DB >> 22842101

Farnesyl pyrophosphate synthase: a key enzyme in isoprenoid biosynthetic pathway and potential molecular target for drug development.

Manoj K Dhar1, Archana Koul, Sanjana Kaul.   

Abstract

As isoprenoid biosynthetic pathway has gained importance since last few years, key enzymes of this pathway have been characterized and their functional roles in the cell metabolism have been explored using molecular biology approaches. A key enzyme in this pathway is farnesyl pyrophosphate (EC 2.5.1.10) synthase (FPPS) which supplies precursors for the biosynthesis of essential isoprenoids like carotenoids, withanolides, ubiquinones, dolichols, sterols, among others and also helps in farnesylation and geranylation of proteins. It is a chain elongation enzyme which catalyzes head to tail condensation of two molecules of isopentenyl diphosphate with dimethylallyl diphosphate to form farnesyl pyrophosphate (FPP). Recent studies have validated FPPS as a molecular target of bisphosphonates for drug development against tumors as well as human pathogens. The present paper synthesizes the information on characterization, structural and functional relationships, evolution, localization as well as advances on FPPS enzyme as a target for drug development.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22842101     DOI: 10.1016/j.nbt.2012.07.001

Source DB:  PubMed          Journal:  N Biotechnol        ISSN: 1871-6784            Impact factor:   5.079


  28 in total

1.  In Vitro and In Vivo Investigation of the Inhibition of Trypanosoma brucei Cell Growth by Lipophilic Bisphosphonates.

Authors:  Gyongseon Yang; Wei Zhu; Kuglae Kim; Soo Young Byun; Gahee Choi; Ke Wang; Jeong Seok Cha; Hyun-Soo Cho; Eric Oldfield; Joo Hwan No
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

2.  Pharmacophore modeling, docking and molecular dynamics to identify Leishmania major farnesyl pyrophosphate synthase inhibitors.

Authors:  Larissa de Mattos Oliveira; Janay Stefany Carneiro Araújo; David Bacelar Costa Junior; Isis Bugia Santana; Angelo Amâncio Duarte; Franco Henrique Andrade Leite; Raquel Guimarães Benevides; Manoelito Coelho Dos Santos Junior
Journal:  J Mol Model       Date:  2018-10-16       Impact factor: 1.810

3.  Identifying Structural Determinants of Product Specificity in Leishmania major Farnesyl Diphosphate Synthase.

Authors:  Sweta Maheshwari; Yu Seon Kim; Srinivas Aripirala; Michael Murphy; L Mario Amzel; Sandra B Gabelli
Journal:  Biochemistry       Date:  2020-07-12       Impact factor: 3.162

Review 4.  Targeting prenylation inhibition through the mevalonate pathway.

Authors:  Pimyupa Manaswiyoungkul; Elvin D de Araujo; Patrick T Gunning
Journal:  RSC Med Chem       Date:  2019-12-23

Review 5.  Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future.

Authors:  José Saura-Esteller; Milon de Jong; Lisa A King; Erik Ensing; Benjamin Winograd; Tanja D de Gruijl; Paul W H I Parren; Hans J van der Vliet
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

6.  Molecular Cloning and Functional Analysis of DXS and FPS Genes from Zanthoxylum bungeanum Maxim.

Authors:  Lu Tian; Jingwei Shi; Lin Yang; Anzhi Wei
Journal:  Foods       Date:  2022-06-14

7.  Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.

Authors:  Jürgen Borlak; Prashant Singh; Giuseppe Gazzana
Journal:  BMC Genomics       Date:  2015-02-25       Impact factor: 3.969

8.  Molecular characterization of farnesyl pyrophosphate synthase from Bacopa monniera by comparative modeling and docking studies.

Authors:  Rishi Kishore Vishwakarma; Krunal Arvind Patel; Prashant Sonawane; Somesh Singh; Uma Kumari; Dinesh Chandra Agrawal; Bashir Mohammad Khan
Journal:  Bioinformation       Date:  2012-11-13

9.  Alteration of mevalonate pathway in proliferated vascular smooth muscle from diabetic mice: possible role in high-glucose-induced atherogenic process.

Authors:  Guo-Ping Chen; Xiao-Qin Zhang; Tao Wu; Liang Li; Jie Han; Chang-Qing Du
Journal:  J Diabetes Res       Date:  2015-03-30       Impact factor: 4.011

10.  Structural characterization of substrate and inhibitor binding to farnesyl pyrophosphate synthase from Pseudomonas aeruginosa.

Authors:  Jason W Schmidberger; Robert Schnell; Gunter Schneider
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.